Same Pill, 171x the Price: The Interstate Drug Pricing Scandal Hidden in Medicaid Data

Key Points

• This research aims to uncover the vast disparities in drug pricing across state lines within Medicaid data.
• Analysis of Medicaid pricing data for pharmaceuticals
• Comparison of prices across different states
• Identification of significant pricing discrepancies
• Some drugs showed price differences as high as 171 times between states
• The findings indicate systemic issues in drug pricing practices
• Identified patterns suggesting potential market manipulation